128 related articles for article (PubMed ID: 38335717)
1. Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow.
Heideman DAM; Berkhof J; Verhoef L; Ouwerkerk C; Smit PW; Oštrbenk Valenčak A; Mlakar J; Poljak M; Steenbergen RDM; Bleeker MCG
J Clin Virol; 2024 Apr; 171():105649. PubMed ID: 38335717
[TBL] [Abstract][Full Text] [Related]
2. Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening.
Heideman DAM; Oštrbenk Valenčak A; Doorn S; Bonde J; Hillemanns P; Gimpelj Domjanič G; Mlakar J; Hesselink AT; Meijer CJLM; Poljak M
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632634
[TBL] [Abstract][Full Text] [Related]
3. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.
Polman NJ; Ebisch RMF; Heideman DAM; Melchers WJG; Bekkers RLM; Molijn AC; Meijer CJLM; Quint WGV; Snijders PJF; Massuger LFAG; van Kemenade FJ; Berkhof J
Lancet Oncol; 2019 Feb; 20(2):229-238. PubMed ID: 30658933
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel.
Heideman DAM; Xu L; Hesselink AT; Doorn S; Ejegod DM; Pedersen H; Quint WGV; Bonde J; Arbyn M
J Clin Virol; 2019 Dec; 121():104201. PubMed ID: 31629967
[TBL] [Abstract][Full Text] [Related]
5. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
[TBL] [Abstract][Full Text] [Related]
6. Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.
Oštrbenk Valenčak A; Cuschieri K; Connor L; Zore A; Smrkolj Š; Poljak M
J Clin Virol; 2024 Feb; 170():105638. PubMed ID: 38183829
[TBL] [Abstract][Full Text] [Related]
7. Clinical Performance of the RealTi
Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Tjalma WAA; Doyen J; Donders G; De Sutter P; Vorsters A; Peeters E; Arbyn M
Microbiol Spectr; 2022 Oct; 10(5):e0163122. PubMed ID: 36047900
[TBL] [Abstract][Full Text] [Related]
8. Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening.
Hesselink AT; Sahli R; Berkhof J; Snijders PJ; van der Salm ML; Agard D; Bleeker MC; Heideman DA
J Clin Virol; 2016 Mar; 76():36-9. PubMed ID: 26809131
[TBL] [Abstract][Full Text] [Related]
9. Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening.
Bellosillo B; Ibáñez R; Roura E; Monfil L; Asensio-Puig L; Álvarez I; Muset M; Florencia Y; Paytubi S; de Andrés-Pablo Á; Calvo S; Serrano-Munné L; Pavón MÁ; Lloveras B
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611001
[TBL] [Abstract][Full Text] [Related]
10. Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples.
Avian A; Clemente N; Mauro E; Isidoro E; Di Napoli M; Dudine S; Del Fabro A; Morini S; Perin T; Giudici F; Cammisuli T; Foschi N; Mocenigo M; Montrone M; Modena C; Polenghi M; Puzzi L; Tomaic V; Valenti G; Sola R; Zanolla S; Vogrig E; Riva E; Angeletti S; Ciccozzi M; Castriciano S; Pachetti M; Petti M; Centonze S; Gerin D; Banks L; Marini B; Canzonieri V; Sopracordevole F; Zanconati F; Ippodrino R
J Transl Med; 2022 May; 20(1):231. PubMed ID: 35581584
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.
Arbyn M; Verdoodt F; Snijders PJ; Verhoef VM; Suonio E; Dillner L; Minozzi S; Bellisario C; Banzi R; Zhao FH; Hillemanns P; Anttila A
Lancet Oncol; 2014 Feb; 15(2):172-83. PubMed ID: 24433684
[TBL] [Abstract][Full Text] [Related]
12. The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening.
Heideman DA; Hesselink AT; van Kemenade FJ; Iftner T; Berkhof J; Topal F; Agard D; Meijer CJ; Snijders PJ
J Clin Microbiol; 2013 Nov; 51(11):3653-7. PubMed ID: 23985912
[TBL] [Abstract][Full Text] [Related]
13. Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples.
Martinelli M; Latsuzbaia A; Bonde J; Pedersen H; Iacobone AD; Bottari F; Piana AF; Pietri R; Cocuzza CE; Arbyn M;
Microbiol Spectr; 2024 Mar; 12(3):e0287223. PubMed ID: 38323823
[TBL] [Abstract][Full Text] [Related]
14. Intra- and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay.
Chung PYJ; Dhillon SK; Baraquin A; Tkachenka Y; Jacquot K; Prétet JL; Broeck DV; Arbyn M
J Med Virol; 2024 Jun; 96(6):e29688. PubMed ID: 38847316
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study.
Inturrisi F; Aitken CA; Melchers WJG; van den Brule AJC; Molijn A; Hinrichs JWJ; Niesters HGM; Siebers AG; Schuurman R; Heideman DAM; de Kok IMCM; Bekkers RLM; van Kemenade FJ; Berkhof J
Lancet Reg Health Eur; 2021 Dec; 11():100235. PubMed ID: 34918001
[TBL] [Abstract][Full Text] [Related]
16. HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system.
Frayle H; Gori S; Rizzi M; Graziani BN; Vian E; Giorgi Rossi P; Del Mistro A
BMC Womens Health; 2019 Mar; 19(1):47. PubMed ID: 30909894
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
Dhillon SK; Cocuzza CE; Chung PYJ; Martinelli M; Giubbi C; Njoku RC; Bhatia R; Cuschieri K; Arbyn M
J Med Virol; 2023 Jan; 95(1):e28417. PubMed ID: 36541733
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening.
Hesselink AT; Heideman DA; Berkhof J; Topal F; Pol RP; Meijer CJ; Snijders PJ
J Clin Microbiol; 2010 Mar; 48(3):797-801. PubMed ID: 20042622
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
[TBL] [Abstract][Full Text] [Related]
20. Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN.
Dijkstra MG; Heideman DA; van Kemenade FJ; Hogewoning KJ; Hesselink AT; Verkuijten MC; van Baal WM; Boer GM; Snijders PJ; Meijer CJ
J Clin Virol; 2012 Jun; 54(2):147-51. PubMed ID: 22445557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
